Jan 31, 2023

Pfizer’s 2022 sales top $100 billion but end to COVID-19 bonanza imminent

The Pharma Letter

US drugmaker Pfizer (NYSE: PFE) cemented its place at the top of the pile of global pharma companies in delivering its 2022 financial results.